Troubling news from Asia about treating enteric fever: a coming storm
In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should...
محفوظ في:
المؤلف الرئيسي: | Ryan, Edward T |
---|---|
التنسيق: | Technical Report |
اللغة: | en_US |
منشور في: |
Lancet Infect Dis 2016
2016
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://103.69.126.140:8080/handle/123456789/817 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomized controlled trial
بواسطة: Arjyal, Amit, وآخرون
منشور في: (2016) -
Study on incidence of Nalidixic acid resistant Salmonella enterica serovar Typhi and Salmonella entrica serovar Paratyphi A and their antibiotic susceptibilities.
بواسطة: Giri, Shudij
منشور في: (2012) -
Control of yellow fever Field Guide
منشور في: (2005) -
Frequently asked questions on chikungunya fever
منشور في: (2013) -
Knowledge, attitude and practice regarding dengue fever among the healthy population of highland and lowland communities in central Nepal.
بواسطة: Dhimal, Meghnath Aryal, Krishna Kumar Dhimal, Mandira Lamichhane Gautam, Ishan Singh, Shanker Pratap Bhusal, Chop Lal Kuch, Ulrich
منشور في: (2014)